Advocacy/Public Policy
The Indiana Health Industry Forum provides guidance and leadership on public policy issues that affect the competitiveness of the health and life science industries in the state. This includes identifying policies and legislation that impact the industries, providing position and policy statements for the approval of the IHIF board of directors, and developing policies that will favorably affect the industries. IHIF also promotes Indiana sectors of excellence to a broad audience.
BIO Fly-In 2010
Issue Briefings provided by BIO
IHIF Public Policy Committee
Mission statement: To provide guidance and leadership on public policy issues that affect the competitiveness of the health and life science industries in the state of Indiana.
Objectives:
- To identify policies and legislation that impact the industries
- To provide position and policy statements for the approval of the IHIF board of directors
- To develop policies that will favorably affect the industries
Activities:
Clinical Trials Working Groups - Working to identify how Indiana can develop a competitive advantage in clinical trials activity. Sub-committees are examining how to conduct more trials in the state, the advantages of state or regional IRBs, the incentive structure for clinical research, and comparing IN to other state and national programs.
Statewide Strategic Plan – Oversee main committee and identify special working groups to evaluate needs and make recommendations
Life Science Day at Statehouse – Organize informational display
Bio-Caucus – Assemble strategic group of legislators to inform on relevant issues.
Recent Activities
June 2010
Special briefing for IHIF members only on proposed changes to the 510(k) approval process - presented by Ralph Hall, Baker & Daniels LLP
May 2010
Webinar For IHIF Members only on "10 Common Misperceptions on the R&D Tax Credit Program", presented by The FreeMind Group, LLC
April 2010
BIO Webinar on Understanding the Therapeutic R&D Tax Credit
Clinical Trials Working Group held second networking event
Participated in BIO-Fly-In to meet with members and legislative staff of the Indiana Congressional Delegation in Washington, D.C.
January 2010
Clinical Trials Working Group held first networking event. More planned!
IHIF sent letters to House members supporting a therapeutic discovery tax credit for small businesses
IHIF sent letters to Senators and House members asking them to continue supporting a 12 year period of data exclusivity for biologics
December 2009
IHIF signed on to a joint position letter sent to Indiana Senators Bayh and Lugar
IHIF Life Science Lunch - Healthcare Reform:Impacts on Innovation
November 2009
IHIF signed on to BIO-sponsored letter to Congressman Donnelly supporting amendment of the Investor Protection Act
October 2009
IHIF sent letters to Senators Bayh and Lugar supporting 12 year patent protection for biologic drugs
IHIF signed on to letter to Senators Bayh and Lugar opposing tax on medical device industry
September 2009
IHIF hosted Healthcare Reform Conference on Sept. 9
IHIF met with Congressman Joe Donnelly in South Bend
IHIF sent letters of opposition on proposed tax on medical device industry to Senators Bayh and Lugar
IHIF signed on to a BIO-sponsored letter supporting HR 422 and S1203 support for permanent and strengthened R&D tax credit
August 2009
IHIF met with Congressman Baron Hill in New Albany
With PhRMA and Hoosiers Work for Health, included IHIF logo on ads encouraging Indiana legislators to participate in bi-partisan healthcare reform efforts
July 2009
Hosted Hoosiers Work for Health panel discussion on healthcare innovation
IHIF signed on to BIO-sponsored letter of support for Eschoo-Barton amendment for support of patent protection for biologic drugs
Senator Lugar's statement on Healthcare Reform
Senator Bayh's position statement on Healthcare
Contact Indiana Legislators
Indiana Federal Congressional Delegation
Partner Organizations
|


